Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer (Scientific Reports, (2020), 10, 1, (3470), 10.1038/s41598-020-60409-4)
Journal
Scientific Reports
Journal Volume
11
Journal Issue
1
Date Issued
2021
Author(s)
Moufarrij S
Srivastava A
Gomez S
Hadley M
Palmer E
Austin P.T
Chisholm S
Diab N
Roche K
Li J
Zhu W
Lopez-Acevedo M
Villagra A
Chiappinelli K.B.
Abstract
Noor Diab was omitted from the author list in the original version of this Article. The Author Contributions section now reads: S.M., A.S., M.L.-A., A.V., and K.B.C. designed the experiments. S.M., A.S., S.G., M.H., P.T.A., S.C., E.P., K.R., N.D., and A.Y. performed experiments. J.L. and W.Z. provided cisplatin-resistant cell lines IGROV-1 CR and SKOV3 CR. S.M., A.S., S.G., A.V., and K.B.C. wrote, edited, and revised the manuscript. The original Article and accompanying Supplementary Information file has been corrected. © The Author(s) 2021.
SDGs
Other Subjects
erratum
Type
corrigendum